Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chromosome 5p
100%
Germline Alterations
100%
Clinical Significance
100%
Glioma
100%
CCDC26
83%
RTEL1
83%
5p15
83%
8q24
83%
9p21
66%
Pathologic
66%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
66%
University of California
33%
Glioblastoma
33%
San Francisco
33%
Glioma Subtypes
16%
Oligodendroglioma
16%
Genetic Analysis
16%
Polymorphism
16%
Germline Polymorphism
16%
Prevalence Risk
16%
Genome-wide Association Study
16%
Specific Aims
16%
High-grade Astrocytoma
16%
Histopathologic
16%
Clinical Parameters
16%
Somatic Expression
16%
Germline
16%
Grant Applications
16%
Somatic Genetic Alterations
16%
Expression Alteration
16%
Germline Genetics
16%
Relative Risk
16%
SNP Array
16%
SNP Mapping
16%
Penetrance
16%
Anaplastic Astrocytoma
16%
Biochemistry, Genetics and Molecular Biology
Germline
100%
Chromosome 5p
100%
Germ Cell
100%
Cyclin Dependent Kinase Inhibitor 2A
66%
Genetics
33%
Prevalence
16%
Penetrance
16%
Single Nucleotide Polymorphism
16%
Single-Nucleotide Polymorphism
16%
Genome-Wide Association Study
16%